Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Operating Income
Forecast
Operating Income Estimate
Changzhou Qianhong Biopharma Co Ltd
For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 23%.
Net Income
Forecast
Net Income Estimate
Changzhou Qianhong Biopharma Co Ltd
For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's net income is 6%. The projected CAGR for the next 2 years is 14%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Changzhou Qianhong Biopharma Co Ltd's stock price target?
Not Available
Changzhou Qianhong Biopharma Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Changzhou Qianhong Biopharma Co Ltd's Revenue forecast?
Projected CAGR
24%
For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's revenue is 9%. The projected CAGR for the next 3 years is 24%.
What is Changzhou Qianhong Biopharma Co Ltd's Operating Income forecast?
Projected CAGR
23%
For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 23%.
What is Changzhou Qianhong Biopharma Co Ltd's Net Income forecast?
Projected CAGR
14%
For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's net income is 6%. The projected CAGR for the next 2 years is 14%.